Sonoma Pharmaceuticals

$7.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.34 (+4.99%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SNOA and other stocks, options, and ETFs commission-free!

About SNOA

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA. The listed name for SNOA is Sonoma Pharmaceuticals, Inc. Common Stock.

CEO
Amy M. Trombly
Employees
298
Headquarters
Woodstock, Georgia
Founded
1999
Market Cap
17.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
38.86K
High Today
$7.30
Low Today
$6.65
Open Price
$6.80
Volume
47.93K
52 Week High
$19.60
52 Week Low
$3.55

SNOA Earnings

-$2.45
-$1.61
-$0.76
$0.08
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
-$0.31 per share

You May Also Like

GDMA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure